EUVIMEDEUVIMED entdecken
Crossref

Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy

Francesco Claps iD, Maaike W van de Kamp, Roman Mayr, Peter J Bostrom, Shahrokh F Shariat, Katrin Hippe, Simone Bertz, Yann Neuzillet, Joyce Sanders, Wolfgang Otto, Michiel S van der Heijden, Michael A S Jewett iD und 20 weitere

BJU International · 2023-08 · 132 (2) · 170-180

DOI: 10.1111/bju.15984 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJU International, online erschienen am 20.02.2023. Verfasst von Francesco Claps und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Carcinoma, Transitional Cell. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate variant histologies (VHs) for disease‐specific survival (DSS) in patients with invasive urothelial bladder cancer (BCa) undergoing radical cystectomy (RC). Materials and Methods We analysed a multi‐institutional cohort of 1082 patients treated with upfront RC for cT1‐4aN0M0 urothelial BCa at eight centres. Univariable and multivariable Cox’ regression analyses were used to assess the effect of different VHs on DSS in overall cohort and three stage‐based analyses. The stages were defined as ‘organ‐confined’ (≤pT2N0), ‘locally advanced’ (pT3‐4N0) and ‘node‐positive’ (pTanyN1‐3).

Results

Overall, 784 patients (72.5%) had pure urothelial carcinoma (UC), while the remaining 298 (27.5%) harboured a VH. Squamous differentiation was the most common VH, observed in 166 patients (15.3%), followed by micropapillary (40 patients [3.7%]), sarcomatoid (29 patients [2.7%]), glandular (18 patients [1.7%]), lymphoepithelioma‐like (14 patients [1.3%]), small‐cell (13 patients [1.2%]), clear‐cell (eight patients [0.7%]), nested (seven patients [0.6%]) and plasmacytoid VH (three patients [0.3%]). The median follow‐up was 2.3 years. Overall, 534 (49.4%) disease‐related deaths occurred. In uni‐ and multivariable analyses, plasmacytoid and small‐cell VHs were associated with worse DSS in the overall cohort (both P = 0.04). In univariable analyses, sarcomatoid VH was significantly associated with worse DSS, while lymphoepithelioma‐like VH had favourable DSS compared to pure UC. Clear‐cell ( P = 0.015) and small‐cell ( P = 0.011) VH were associated with worse DSS in the organ‐confined and node‐positive cohorts, respectively.

Conclusions

More than 25% of patients harboured a VH at time of RC. Compared to pure UC, clear‐cell, plasmacytoid, small‐cell and sarcomatoid VHs were associated with worse DSS, while lymphoepithelioma‐like VH was characterized by a DSS benefit. Accurate pathological diagnosis of VHs may ensure tailored counselling to identify patients who require more intensive management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCarcinoma, Transitional CellHumansPrognosisCystectomyRetrospective Studies

Stichwörter der Autor:innen

#BladderCancer#blcsm#uroonc#utucbladder urothelial carcinomaprognosisradical cystectomysurvivalvariant histology

Autor:innen und Institutionen

  • Department of Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Urological Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
  • Department of Urology, Caritas St Josef Medical Center, University of Regensburg, Regensburg, Germany.
  • Department of Surgery (Urology) and Surgical Oncology, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada.
  • Department of Urology, Turku University Hospital and University of Turku, Turku, Finland.
  • Department of Urology, University of Texas Southwestern Medical center, Dallas, TX, USA.

ORCID-Profile: Francesco Claps, Michael A S Jewett, Laura S Mertens, Nicola Pavan, M Carmen Mir, Yair Lotan

Zitieren

APA

Claps, F., van de Kamp, M. W., Mayr, R., Bostrom, P. J., Shariat, S. F., Hippe, K., Bertz, S., Neuzillet, Y., Sanders, J., Otto, W., van der Heijden, M. S., Jewett, M. A. S., Stöhr, R., Zlotta, A. R., Trombetta, C., Eckstein, M., Mertens, L. S., Burger, M., Soorojebally, Y., …, & van Rhijn, B. W. G. (2023). Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy. BJU International, 132(2), 170-180. https://doi.org/10.1111/bju.15984

Vancouver

Claps F, van de Kamp MW, Mayr R, Bostrom PJ, Shariat SF, Hippe K, et al. Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy. BJU International. 2023;132(2):170-180. doi:10.1111/bju.15984

BibTeX
@article{Claps2023,
  author = {Claps, Francesco and van de Kamp, Maaike W and Mayr, Roman and Bostrom, Peter J and Shariat, Shahrokh F and Hippe, Katrin and Bertz, Simone and Neuzillet, Yann and Sanders, Joyce and Otto, Wolfgang and van der Heijden, Michiel S and Jewett, Michael A S and Stöhr, Robert and Zlotta, Alexandre R and Trombetta, Carlo and Eckstein, Markus and Mertens, Laura S and Burger, Maximilian and Soorojebally, Yanish and Wullich, Bernd and Bartoletti, Riccardo and Radvanyi, François and Pavan, Nicola and Sirab, Nanour and Mir, M Carmen and Pouessel, Damien and van der Kwast, Theo H and Hartmann, Arndt and Lotan, Yair and Bussani, Rossana and Allory, Yves and van Rhijn, Bas W G},
  title = {Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy},
  journal = {BJU International},
  year = {2023},
  volume = {132},
  number = {2},
  pages = {170--180},
  doi = {10.1111/bju.15984}
}
Kostenlos starten →